載入...
Metastatic phenotype in CWR22 prostate cancer xenograft following castration
BACKGROUND: CWR22 is a human xenograft model of primary prostate cancer (PCa) that is often utilized to study castration recurrent (CR) PCa. CWR22 recapitulates clinical response to androgen deprivation therapy (ADT), in that tumors regress in response to castration, but can recur after a period of...
Na minha lista:
| 發表在: | Prostate |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4745026/ https://ncbi.nlm.nih.gov/pubmed/26642837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23127 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|